A clinical trial to study the effects of 1064 nm Q Switched Nd-YAG laser and glycolic acid peel in patients with macular amyloidosis
Phase 3
- Conditions
- Health Condition 1: E854- Organ-limited amyloidosis
- Registration Number
- CTRI/2024/05/066757
- Lead Sponsor
- Command Hospital Air Force Bangalore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged =18 years of either sex, Patients with macular amyloidosis,Patients who are not on any topical/oral/laser therapy for last 01 month, Patients with written informed consent by self or by guardian
Exclusion Criteria
Patient with history of any treatment for macular amyloidosis in last 01 month, Pregnant females, Photosensitive dermatoses, Patients with known hypersensitivity to chemical peels, Patients with unrealistic expectations, Patients will be dropped from the study if any adverse effect noticed after test patch
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Color score will be used before and 1 month after the treatment in both the groupsTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method Dermoscopic findingsTimepoint: 6 months;Subjective improvementTimepoint: 6 months;VAS (Visual Analogue Scale) - Will be done 1 month after completion of treatmentTimepoint: 6 months